| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.005 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |